One of the first studies on this topic was published in 2010 by Merkel et al. [118], who described the upregulation of miR-17–92 cluster members in ALK+ ALCL in cell lines, transgenic mouse models and primary tumor tissues [118], which activates STAT3 [119]. Here, ALK is linked to neoplasm.